(August 18, 2016, 12:45 PM EDT) -- WASHINGTON, D.C. — Findings by the Patent Trial and Appeal Board that 23 claims of a patented composition for tigecycline and an acid or buffer are not obvious were not erroneous,...
Patent Board’s Rejection Of Obviousness Challenge Affirmed By Federal Circuit
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login